Cat.#: ACPP-1622
Despition | DLK1 Human Recombinant |
SIZE | 2 µg |
Purity | > 95.0% (SDS-PAGE) |
Form | Sterile Filtered clear solution. |
Storage | Store at 4°C for 2-4 weeks. |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1354 | PAX2 Blocking Peptide (AC1354) | 250 µg | inquiry |
ACPP-1714 | Human PGR Protein (AC1714) | 2 µg | inquiry |
ACPP-1237 | CRMP1 Blocking Peptide (AC1237) | 250 µg | inquiry |
ACPP-1339 | MRAP2 Blocking Peptide (AC1339) | 250 µg | inquiry |
ACPP-1701 | Human SERPINA3 Protein (AC1701) | 5 µg | inquiry |
ACPP-1379 | Human OLFM1 Protein (AC1379) | 2 µg | inquiry |
ACPP-1418 | Human GAL Protein (AC1418) | 2 µg | inquiry |
ACPP-1265 | EDG8 Blocking Peptide (AC1265) | 250 µg | inquiry |
ACPP-1018 | Recombinant Human APLP2 Protein (6×His Tag) (AC1018) | 50 µg | inquiry |
ACPP-1099 | Synthetic Nanodisc Human Adenosine Receptor A2a Protein (AC1099) | 10 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.